1. Home
  2. PFS vs SRPT Comparison

PFS vs SRPT Comparison

Compare PFS & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Services Inc

PFS

Provident Financial Services Inc

HOLD

Current Price

$22.67

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.60

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFS
SRPT
Founded
1839
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
2002
2000

Fundamental Metrics

Financial Performance
Metric
PFS
SRPT
Price
$22.67
$17.60
Analyst Decision
Strong Buy
Hold
Analyst Count
4
29
Target Price
$23.75
$25.85
AVG Volume (30 Days)
819.4K
2.6M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
4.28%
N/A
EPS Growth
112.38
N/A
EPS
0.61
2.88
Revenue
$73,109,000.00
$2,198,237,000.00
Revenue This Year
$0.68
N/A
Revenue Next Year
$5.97
N/A
P/E Ratio
$36.85
$5.88
Revenue Growth
7.06
15.58
52 Week Low
$16.08
$10.42
52 Week High
$23.98
$25.32

Technical Indicators

Market Signals
Indicator
PFS
SRPT
Relative Strength Index (RSI) 52.62 54.78
Support Level $21.52 $16.67
Resistance Level $22.86 $18.16
Average True Range (ATR) 0.51 0.84
MACD 0.02 0.28
Stochastic Oscillator 54.77 84.58

Price Performance

Historical Comparison
PFS
SRPT

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: